Effectiveness of the WHO ICOPE (Integrated Care for Older People) Program in Preventing Age-related Functional Decline (ICOPE Trial.Fr)

Launched by UNIVERSITY HOSPITAL, TOULOUSE · Nov 5, 2024

Keywords

ClinConnect Summary

The ICOPE Trial is studying a program created by the World Health Organization to help older adults maintain their independence and prevent problems related to aging. The program includes steps like screening for common issues (such as mobility, thinking, nutrition, vision, hearing, and mental health), a thorough evaluation if problems are found, and a personalized care plan to help each individual. The goal is to see if following this comprehensive approach is more effective than the usual care older adults receive from their doctors.

To participate in this trial, you need to be at least 70 years old and live independently at home, showing signs of decline in at least two of the six areas mentioned. Participants will undergo regular assessments and follow-up care over the course of the study. It's important to note that those living in care facilities or with certain disabilities may not be eligible. Overall, the trial aims to provide valuable insights into how to better support older adults and enhance their quality of life.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Participants aged 65 years and older.
• • 2. Participants living independently at home (ADL = 6, except for an occasional urinary abnormality which will be accepted).
• • 3. Participants showing functional decline in at least 2 of the 6 functional domains of ICOPE (mobility, cognition, nutrition, vision, hearing, and psychological well-being) identified using the ICOPE screening tool.
• • 4. Participants affiliated with a social protection system.
• Exclusion Criteria:
• • 1. Participants who has already benefited from the ICOPE program or who has completed more than one isolated step 1
• • 2. Participants living in a dependent elderly care facility.
• • 3. Participants with a disability preventing them from reaching the trial examination center without assistance (such as dementia or significant mobility impairment).
• • 4. Participants with hearing, visual, or speech impairments preventing them from understanding instructions or communicating with study staff.
• • 5. Participants with a life-threatening illness with a prognosis of less than 5 years.
• • 6. Participants unable to provide informed written consent.
• • 7. Participants under legal protection, guardianship, or trusteeship.
• • 8. Participants participating in another interventional research study.
• • 9. Participants in a relationship with a person participating in the study.